Enhancer of Zeste 1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophrenia.
CONCLUSIONS: EZH1 is dysregulated in schizophrenia, sensitive to antipsychotic medications, and a brain-enriched miR-132 target that controls neurobehavioral phenotypes.
PMID: 30099093 [PubMed - as supplied by publisher]
Source: Neurobiology of Disease - Category: Neurology Authors: Johnstone AL, O'Reilly JJ, Patel AJ, Guo Z, Andrade NS, Magistri M, Nathanson L, Esanov R, Miller BH, Turecki G, Brothers SP, Zeier Z, Wahlestedt C Tags: Neurobiol Dis Source Type: research
More News: Brain | Environmental Health | Genetics | Men | Nanotechnology | Neurology | Schizophrenia